Status:

RECRUITING

The Role of Ceus in the Characterization of Focal Liver Lesions Indeterminate to Second-level Methods

Lead Sponsor:

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Conditions:

Focal Liver Lesion

Eligibility:

All Genders

18+ years

Brief Summary

The primary objective of the study is to determine the accuracy of CEUS in characterizing (as benign or malignant) focal liver lesions for which CT, MRI and/or PET have not been conclusive.

Detailed Description

The study conducted will be a non-profit, observational, non-pharmacological, cross-sectional, but also partly cohort, retrospective and prospective study. The study is cross-sectional in nature, but ...

Eligibility Criteria

Inclusion

  • Age ≥18 years.
  • CEUS performed performed in the last 6 months a CT, MRI and/or PET not decisive in characterizing a liver lesion.
  • Obtaining informed consent.

Exclusion

  • Technical impossibility to perform the ultrasound evaluation.
  • Documented allergy to the ultrasound contrast medium.

Key Trial Info

Start Date :

August 1 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

April 1 2027

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT06876805

Start Date

August 1 2024

End Date

April 1 2027

Last Update

March 14 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Policlinico Sant'Orsola Malpighi

Bologna, Italy, 40138